Detalhe da pesquisa
1.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet
; 392(10143): 222-231, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043749
2.
Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.
Rheumatology (Oxford)
; 57(5): 900-908, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415145
3.
Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
Seizure
; 97: 50-57, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325842
4.
Clinical development of valbenazine for tics associated with Tourette syndrome.
Expert Rev Neurother
; 21(4): 393-404, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682568
5.
Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.
Arthritis Res Ther
; 19(1): 208, 2017 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923098